This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Prelude Therapeutics Incorporated. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sina Rezazadeh and BRM-Targeting Compounds
Introduction
Sina Rezazadeh is an inventor associated with Newark, Delaware, and Prelude Therapeutics Incorporated. His patent work concerns compounds designed to target BRM, a protein involved in gene regulation.
Latest Patents
Rezazadeh is named on one patent, titled “BRM Targeting Compounds and Associated Methods of Use.” The disclosure describes compounds of Formula I, pharmaceutical compositions containing those compounds, and methods for their preparation and use. The patent record provided does not establish when this was his latest patent.
Career Highlights
Rezazadeh’s listed patent reflects research into therapeutic compounds and their potential pharmaceutical applications. His work is associated with Prelude Therapeutics Incorporated.
Collaborations
The patent information also names Corey Howard Basch and Song Mei as coworkers associated with Rezazadeh’s work.
Conclusion
Sina Rezazadeh’s recorded invention focuses on BRM-targeting compounds and related pharmaceutical compositions and methods, connecting his patent activity with therapeutic research at Prelude Therapeutics Incorporated. 1 patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile